Officers and Directors
John Shulman is Founder and Managing Partner of Juggernaut Capital Partners, a leading private equity firm with over $1 billion in committed capital. Mr. Shulman currently serves on the Boards of Directors of Metuchen Pharmaceuticals (Rx Pharmaceuticals) and Foundation Consumer Healthcare (OTC Pharmaceuticals). Previously, he served on the Boards of Directors of Triax Pharmaceuticals (Rx Pharmaceuticals) and Insight Pharmaceuticals (OTC Pharmaceuticals).
Mr. Shulman holds a B.S. degree in Finance from The McIntire School of Commerce at the University of Virginia.
Mr. Silverman is the Co–founder and Managing Member of Parkfield Funding LLC, and is a former Principal and Managing Partner of Iroquois Capital Management, LLC. Mr. Silverman served as Co–Chief Investment Officer of Iroquois from 2003 until July 2016. From 2000 to 2003, Mr. Silverman served as Co–Chief Investment Officer of Vertical Ventures, LLC, a merchant bank. Prior to forming Iroquois, Mr. Silverman was a Director of Joele Frank, a boutique consulting firm specializing in mergers and acquisitions. Previously, Mr. Silverman served as Assistant Press Secretary to The President of The United States. Mr. Silverman received his B.A. from Lehigh University in 1992. In the past five years, Mr. Silverman has served as a director of MGT Capital Investments, Inc. and National Holdings Corporation.
Greg Bradley joined Foundation Consumer Healthcare as CEO in October of 2017. Greg has 34 years of experience in the consumer-packaged goods industry with a specific expertise in OTC Healthcare. He has a proven track record in Sales, Marketing, Supply Chain and General Management. Prior to joining Foundation CH, Greg spent much of his career with GlaxoSmithKline Consumer Healthcare (GSK) in senior management roles where he helped create several mega brands within the OTC healthcare landscape, including multiple Rx-OTC switches. In 2011, Greg founded Advantage Consumer Healthcare (ACH), a full-service company specializing in OTC switches, Healthcare product launches and improving in-market performance of existing OTC Healthcare brands.
Mr. Walker founded Walker Nell Partners, Inc. (“Walker Nell”), a financial advisory firm in 2013, where he continues to serve as the managing partner. Walker Nell provides corporate governance and restructuring advisory services, fiduciary services, litigation support, and other services to client corporations and law firms. In his role at Walker Nell, he has served on a number of private company boards. He currently serves as Chairman of the Board of Trustees of National Philanthropic Trust, a public charity that holds over $6 billion of assets under management. Mr. Walker has more than 25 years of experience in corporate law and corporate restructuring, including working 15 years at the DuPont Company.
Bruce T. Bernstein has over thirty years of experience in the securities industry, primarily as a senior portfolio manager for two alternative finance funds as well as a deep understanding of the trading and structuring of arbitrage strategies. Since 2006, Mr. Bernstein has served as President of Rockmore Capital, LLC, a direct investment and lending fund. Previously, Bruce served as Co-President of Omicron Capital, LP, an investment firm based in New York. Prior to joining Omicron Capital, Mr. Bernstein was with Fortis Investments Inc. where he served as a Senior Vice President in the bank`s Global Securities Arbitrage business unit and then President in charge of the bank`s proprietary investment business in the United States. Mr. Bernstein also serves as a member of the board of directors of XpresSpa Holdings, the leading airport spa company in the world. Mr. Bernstein is also a member of the board of Summit Digital Health, a laser based blood glucose monitor distributor. Mr. Bernstein holds a B.B.A. from City University of New York (Baruch).